3401. What does the corpus callosum tell us about brain changes in the elderly?. (November 2011) Authors: Di Paola, Margherita; Caltagirone, Carlo; Spalletta, Gianfranco Journal: Expert review of neurotherapeutics Issue: Volume 11:Number 11(2011) Page Start: 1557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3402. What does the corpus callosum tell us about brain changes in the elderly?. (November 2011) Authors: Di Paola, Margherita; Caltagirone, Carlo; Spalletta, Gianfranco Journal: Expert review of neurotherapeutics Issue: Volume 11:Number 11(2011) Page Start: 1557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3403. What happens when natalizumab therapy is stopped?. (September 2011) Authors: Schaaf, Stephen M; Pitt, David; Racke, Michael K Journal: Expert review of neurotherapeutics Issue: Volume 11:Number 9(2011) Page Start: 1247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3404. What has sex got to do with it? The role of hormones in the transgender brain. (January 2019) Authors: Nguyen, Hillary; Loughead, James; Lipner, Emily; Hantsoo, Liisa; Kornfield, Sara; Epperson, C. Journal: Neuropsychopharmacology Issue: Volume 44:Number 1(2019) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3405. What have we learned from trials on antiangiogenic agents in glioblastoma?. (January 2014) Authors: Soffietti, Riccardo; Trevisan, Elisa; Rudà, Roberta Journal: Expert review of neurotherapeutics Issue: Volume 14:Number 1(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3406. What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications. (March 2021) Authors: Framer, Adele Journal: Therapeutic advances in psychopharmacology Issue: Volume 11(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3407. What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group. (1st December 2020) Authors: Sacco, Simona; Russo, Antonio; Geppetti, Pierangelo; Grazzi, Licia; Negro, Andrea; Tassorelli, Cristina; Tedeschi, Gioacchino; Martelletti, Paolo Journal: Expert review of neurotherapeutics Issue: Volume 20:Number 12(2020) Page Start: 1275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3408. What is hydroxynorketamine and what can it bring to neurotherapeutics?. (November 2014) Authors: Singh, Nagendra S; Zarate, Carlos A; Moaddel, Ruin; Bernier, Michel; Wainer, Irving W Journal: Expert review of neurotherapeutics Issue: Volume 14:Number 11(2014) Page Start: 1239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3409. What is misophonia and how can we treat it?. (April 2014) Authors: Cavanna, Andrea E Journal: Expert review of neurotherapeutics Issue: Volume 14:Number 4(2014) Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3410. What is NODDI and what is its role in Parkinson's assessment?. (3rd March 2016) Authors: Kamagata, Koji; Hatano, Taku; Aoki, Shigeki Journal: Expert review of neurotherapeutics Issue: Volume 16:Number 3(2016) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗